Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease

This publication has 17 references indexed in Scilit:

• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
  New England Journal of Medicine, 2000
• Antiplatelet Agents and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction (SOLVD) Trial
  Journal of the American College of Cardiology, 1998
• Interaction Between Enalapril and Aspirin on Mortality After Acute Myocardial Infarction: Subgroup Analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
  The American Journal of Cardiology, 1997
• ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
  The Lancet, 1995
• Aspirin as an Antiplatelet Drug
  New England Journal of Medicine, 1994
• Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
  Journal of the American College of Cardiology, 1992
• Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1992
• Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
  Circulation, 1989
• Prostaglandins in Severe Congestive Heart Failure
  New England Journal of Medicine, 1984
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958